HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seiji Yano Selected Research

Thyroid Neoplasms (Thyroid Cancer)

1/2021Sarcopenia may Influence the Prognosis in Advanced Thyroid Cancer Patients Treated With Molecular Targeted Therapy.
7/2019Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer.
1/2019Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seiji Yano Research Topics

Disease

139Neoplasms (Cancer)
05/2024 - 06/2002
78Lung Neoplasms (Lung Cancer)
02/2024 - 06/2002
47Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2023 - 06/2002
40Neoplasm Metastasis (Metastasis)
02/2024 - 01/2002
14Malignant Mesothelioma
09/2021 - 01/2006
13Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2017 - 01/2003
12Adenocarcinoma of Lung
02/2023 - 06/2002
8Pleural Effusion (Pleural Effusions)
12/2022 - 01/2006
7Carcinoma (Carcinomatosis)
12/2020 - 11/2010
6Disease Progression
02/2024 - 11/2014
6Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2003
6Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 04/2003
6Adenocarcinoma
07/2015 - 04/2004
5Meningeal Carcinomatosis
09/2021 - 10/2009
5Brain Neoplasms (Brain Tumor)
09/2020 - 01/2002
4Colonic Neoplasms (Colon Cancer)
01/2023 - 03/2005
4Peritoneal Neoplasms
01/2022 - 06/2011
4Prostatic Neoplasms (Prostate Cancer)
10/2021 - 04/2004
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020 - 06/2002
4Mesothelioma
10/2020 - 06/2002
4Hemorrhage
07/2019 - 07/2002
4Malignant Pleural Effusion
02/2007 - 06/2003
3Body Weight (Weight, Body)
11/2023 - 03/2003
3Ascites
01/2022 - 06/2011
3Renal Cell Carcinoma (Grawitz Tumor)
11/2021 - 12/2010
3Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 01/2019
3Carcinogenesis
12/2020 - 01/2018
3Breast Neoplasms (Breast Cancer)
12/2013 - 01/2003
3Neoplasm Micrometastasis
07/2011 - 03/2003
3Ductal Carcinoma
09/2005 - 04/2003
3Pancreatic Ductal Carcinoma
09/2005 - 04/2003
2Cough
03/2024 - 01/2023
2Nausea
06/2023 - 09/2004

Drug/Important Bio-Agent (IBA)

51Tyrosine Kinase InhibitorsIBA
02/2024 - 05/2003
45ErbB Receptors (EGF Receptor)IBA
02/2024 - 01/2003
33Gefitinib (Iressa)FDA Link
01/2023 - 05/2003
22Phosphotransferases (Kinase)IBA
05/2024 - 01/2004
20Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2003
18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2003
17Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2023 - 11/2008
17Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2022 - 11/2008
16osimertinibIBA
02/2024 - 01/2016
14CrizotinibIBA
05/2024 - 07/2012
11alectinibIBA
06/2022 - 07/2014
8Anaplastic Lymphoma KinaseIBA
01/2023 - 07/2012
8LigandsIBA
09/2021 - 11/2008
7Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2023 - 04/2003
7Cisplatin (Platino)FDA LinkGeneric
09/2012 - 11/2004
6Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2024 - 12/2013
6tyrosine receptor (receptor, tyrosine)IBA
01/2018 - 07/2013
5RNA (Ribonucleic Acid)IBA
02/2023 - 04/2017
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022 - 01/2006
5Diphosphonates (Bisphosphonates)IBA
03/2016 - 01/2003
4Tyrosine (L-Tyrosine)FDA Link
05/2024 - 01/2005
4Immune Checkpoint InhibitorsIBA
01/2023 - 02/2020
4Therapeutic UsesIBA
01/2023 - 07/2002
4entrectinibIBA
01/2023 - 12/2017
4AfatinibIBA
01/2022 - 03/2012
4AndrogensIBA
01/2021 - 06/2006
4VorinostatFDA Link
02/2020 - 04/2013
4lenvatinibIBA
07/2019 - 12/2009
4Bevacizumab (Avastin)FDA Link
12/2015 - 10/2007
4Neutralizing AntibodiesIBA
09/2012 - 02/2004
4CytokinesIBA
09/2011 - 03/2003
4Parathyroid Hormone-Related ProteinIBA
01/2009 - 02/2004
3trametinibIBA
09/2021 - 01/2018
3Etoposide (VP 16)FDA LinkGeneric
02/2021 - 11/2003
3EnzymesIBA
01/2021 - 02/2007
3Biomarkers (Surrogate Marker)IBA
12/2020 - 09/2011
3DNA (Deoxyribonucleic Acid)IBA
09/2020 - 04/2004
3Peptides (Polypeptides)IBA
01/2020 - 10/2009
3AmphiregulinIBA
01/2020 - 06/2011
3Histone Deacetylase InhibitorsIBA
01/2020 - 01/2018
3Docetaxel (Taxotere)FDA Link
10/2019 - 03/2003
3CateninsIBA
01/2019 - 08/2015
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2017 - 07/2012
3AntibodiesIBA
01/2015 - 12/2011
3WZ4002IBA
01/2013 - 03/2012
3Cetuximab (Erbitux)FDA Link
11/2012 - 06/2011
3YM 529IBA
01/2009 - 01/2003
3GemcitabineFDA Link
01/2009 - 08/2005
3vandetanib (ZD6474)IBA
06/2008 - 12/2005
3src-Family KinasesIBA
09/2006 - 01/2005
3N- (2- chloro- 5- methoxyphenyl)- 6- methoxy- 7- ((1- methyl- 4- piperidinyl) methoxy) 4-quinazolinamineIBA
09/2006 - 01/2005
3Oxygen (Dioxygen)IBA
04/2006 - 07/2002
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2006 - 01/2003
3Matrix Metalloproteinases (MMPs)IBA
03/2003 - 10/2002
2Carboplatin (JM8)FDA LinkGeneric
06/2023 - 10/2009
2B7-H1 AntigenIBA
02/2023 - 08/2021
2lorlatinibIBA
01/2023 - 01/2019
2Axitinib (AG 013736)IBA
10/2022 - 01/2020
2MicroRNAs (MicroRNA)IBA
05/2022 - 10/2019
2Messenger RNA (mRNA)IBA
01/2022 - 06/2011
2NivolumabIBA
01/2022 - 12/2020
2Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 11/2008

Therapy/Procedure

52Therapeutics
02/2024 - 01/2002
23Drug Therapy (Chemotherapy)
06/2023 - 07/2002
4Combination Drug Therapy (Combination Chemotherapy)
12/2020 - 09/2004
3Aftercare (After-Treatment)
03/2024 - 09/2012
3Radiotherapy
10/2022 - 08/2005